ZTS SEC Filing News — Zoetis Inc.

Latest SEC filings for Zoetis Inc. (ZTS) explained in plain English. Covers insider buying and selling (Form 4), proposed insider sales (Form 144), material company events (8-K), and quarterly & annual reports (10-Q / 10-K). StrongBuyAnalytics provides navigation and brief excerpts or summaries; original filings remain at the SEC/source links and were authored by their filers, not StrongBuyAnalytics. Filing dates shown are source dates. Coverage and detection can be delayed or incomplete because of SEC availability, amendments, parsing, caching, or outages. Latest source filing date shown: 2026-10-13.

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally. The company commercializes products primarily across companion animals comprising dogs, cats, and horses; and species, including livestock, such as cattle, swine, poultry, fish, and sheep. It also offers parasiticides,…
Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic Market Cap: $32.8B CIK: 1555280
20
Total Filings
0
Bullish Classifications
0
Bearish Classifications
15
Insider Transactions
4
Material Events (8-K)
1
Periodic Reports
What you're looking at: Each item below is parsed from an actual SEC filing submitted by Zoetis Inc.. Form 4 = confirmed insider transaction · Form 144 = proposed sale notice · 8-K = material event (earnings, M&A, leadership change, etc.) · 10-Q / 10-K = quarterly / annual report.
ZTS Filing Activity Snapshot 2026-07-14 — 2026-10-13
Insider Transactions (Form 4)
0 buys vs 0 sells
Insider buying and selling activity is balanced in this period.
Insider Transactions 15 · Forms 3, 4 and 5

A Form 4 is filed within two business days of a company insider — an officer, a director, or a holder of more than ten percent of the stock — changing their position in the shares. All 15 filings in this group are Form 4s for Zoetis Inc.

The difficulty with reading these filings as a group is that a single form type covers transactions that mean entirely different things. An executive spending their own money to buy stock and an executive having shares withheld to pay tax on a vesting grant both appear as a Form 4. Every filing below is therefore tagged with the nature of the underlying transaction, taken from the transaction code reported on the form itself.

Across the 15 insider filings shown, the breakdown is 13 compensation award, 1 option exercise and 1 gift. None of the classified filings involved a discretionary open-market trade, so this period says nothing about what insiders think of the price.

What each transaction type means

Compensation award ×13
Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.
Option exercise ×1
The insider converted options into shares. The exercise price was fixed when the options were granted, so the timing usually tracks an expiry schedule.
Gift ×1
Shares were transferred as a gift, typically for estate or charitable planning. No sale into the market took place.
Form 4 Compensation award Tax / Compensation Filing 2026-10-13

ZTS insider Form 4 filed for equity award, exercise, or tax withholding

PECK KRISTIN C (Director, Chief Executive Officer) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code Nature Shares Price Value
A Compensation award derivative · Phantom Stock Unit 720 $26.17 $18.8K
Filing: Form 4 (Insider Transaction) Insider: PECK KRISTIN C (Director, Chief Executive Officer)
Form 4 Compensation award Tax / Compensation Filing 2026-10-13

ZTS insider Form 4 filed for equity award, exercise, or tax withholding

Esch Kevin (Executive Vice President) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code Nature Shares Price Value
A Compensation award derivative · Phantom Stock Unit 360 $26.17 $9.4K
Filing: Form 4 (Insider Transaction) Insider: Esch Kevin (Executive Vice President)
Form 4 Compensation award Tax / Compensation Filing 2026-10-13

ZTS insider Form 4 filed for equity award, exercise, or tax withholding

Driscoll Rimma (Executive Vice President) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code Nature Shares Price Value
A Compensation award derivative · Phantom Stock Unit 277 $26.17 $7.2K
Filing: Form 4 (Insider Transaction) Insider: Driscoll Rimma (Executive Vice President)
Form 4 Compensation award Tax / Compensation Filing 2026-10-13

ZTS insider Form 4 filed for equity award, exercise, or tax withholding

FULLER JULIE (Executive Vice President) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code Nature Shares Price Value
A Compensation award derivative · Phantom Stock Unit 367 $26.17 $9.6K
Filing: Form 4 (Insider Transaction) Insider: FULLER JULIE (Executive Vice President)
Form 4 Compensation award Tax / Compensation Filing 2026-10-13

ZTS insider Form 4 filed for equity award, exercise, or tax withholding

Sarbaugh Keith (Executive Vice President) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code Nature Shares Price Value
A Compensation award derivative · Phantom Stock Unit 303 $26.17 $7.9K
Filing: Form 4 (Insider Transaction) Insider: Sarbaugh Keith (Executive Vice President)
Form 4 Compensation award Tax / Compensation Filing 2026-10-13

ZTS insider Form 4 filed for equity award, exercise, or tax withholding

Ferran Astorga Jeannette (Executive Vice President) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code Nature Shares Price Value
A Compensation award derivative · Phantom Stock Unit 52 $26.17 $1.4K
Filing: Form 4 (Insider Transaction) Insider: Ferran Astorga Jeannette (Executive Vice President)
Form 4 Compensation award Tax / Compensation Filing 2026-10-13

ZTS insider Form 4 filed for equity award, exercise, or tax withholding

Nayak Abhay U (Executive Vice President) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code Nature Shares Price Value
A Compensation award derivative · Phantom Stock Unit 321 $26.17 $8.4K
Filing: Form 4 (Insider Transaction) Insider: Nayak Abhay U (Executive Vice President)
Form 4 Compensation award Tax / Compensation Filing 2026-10-13

ZTS insider Form 4 filed for equity award, exercise, or tax withholding

Lagano Roxanne (Executive Vice President) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code Nature Shares Price Value
A Compensation award derivative · Phantom Stock Unit 367 $26.17 $9.6K
Filing: Form 4 (Insider Transaction) Insider: Lagano Roxanne (Executive Vice President)
Form 4 Option exercise Tax / Compensation Filing 2026-10-02

ZTS insider Form 4 filed for equity award, exercise, or tax withholding

FULLER JULIE (Executive Vice President) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

The insider converted options into shares. The exercise price was fixed when the options were granted, so the timing usually tracks an expiry schedule.

Transactions reported on this filing
Code Nature Shares Price Value
M Option exercise 799 — —
F Tax withholding on vested shares 274 $69.83 $19.1K
M Option exercise derivative · Restricted Stock Unit 799 — —
Filing: Form 4 (Insider Transaction) Insider: FULLER JULIE (Executive Vice President) Shares: 1,073
Form 4 Compensation award Tax / Compensation Filing 2026-09-18

ZTS insider Form 4 filed for equity award, exercise, or tax withholding

Stetter Mark (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code Nature Shares Price Value
A Compensation award derivative · Phantom Stock Unit 342 $73.02 $25.0K
Filing: Form 4 (Insider Transaction) Insider: Stetter Mark (Director)
Form 4 Compensation award Tax / Compensation Filing 2026-09-02

ZTS insider Form 4 filed for equity award, exercise, or tax withholding

SACCARO JAMES (EVP, CFO & COO) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code Nature Shares Price Value
A Compensation award derivative · Restricted Stock Unit 81,063 — —
Filing: Form 4 (Insider Transaction) Insider: SACCARO JAMES (EVP, CFO & COO)
Form 4 Gift Tax / Compensation Filing 2026-08-11

ZTS insider Form 4 filed for equity award, exercise, or tax withholding

DAMELIO FRANK A (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were transferred as a gift, typically for estate or charitable planning. No sale into the market took place.

Transactions reported on this filing
Code Nature Shares Price Value
G Gift 6,650 — —
Filing: Form 4 (Insider Transaction) Insider: DAMELIO FRANK A (Director) Shares: 6,650
Form 4 Compensation award Tax / Compensation Filing 2026-07-14

ZTS insider Form 4 filed for equity award, exercise, or tax withholding

Sarbaugh Keith (Executive Vice President) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code Nature Shares Price Value
A Compensation award derivative · Phantom Stock Unit 259 $26.22 $6.8K
Filing: Form 4 (Insider Transaction) Insider: Sarbaugh Keith (Executive Vice President)
Form 4 Compensation award Tax / Compensation Filing 2026-07-14

ZTS insider Form 4 filed for equity award, exercise, or tax withholding

PECK KRISTIN C (Director, Chief Executive Officer) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code Nature Shares Price Value
A Compensation award derivative · Phantom Stock Unit 616 $26.22 $16.2K
Filing: Form 4 (Insider Transaction) Insider: PECK KRISTIN C (Director, Chief Executive Officer)
Form 4 Compensation award Tax / Compensation Filing 2026-07-14

ZTS insider Form 4 filed for equity award, exercise, or tax withholding

Nayak Abhay U (Executive Vice President) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code Nature Shares Price Value
A Compensation award derivative · Phantom Stock Unit 214 $26.22 $5.6K
Filing: Form 4 (Insider Transaction) Insider: Nayak Abhay U (Executive Vice President)
Material Events 4 · Form 8-K

An 8-K reports a material event in the window between scheduled reports. There are 4 in this period for Zoetis Inc. Each 8-K names the item number it is filed under, and that number is the fastest way to tell a routine disclosure from a consequential one.

Item 2.02 is an earnings release, Item 5.02 is a change of directors or officers, and Item 1.01 or 2.01 covers a material agreement or a completed acquisition. Item 7.01 and Item 8.01 are the general-purpose disclosure items and carry no fixed meaning on their own.

Form 8-K Material Company Update 2026-10-13

ZTS filed 8-K — material company event

Zoetis Inc. filed an 8-K with the SEC reporting a material event. Summary unavailable — view the original SEC filing for the full text.

Filing: 8-K (Material Event)
Form 8-K Material Company Update 2026-10-08

ZTS filed 8-K — material company event

Zoetis Inc. filed an 8-K with the SEC reporting a material event. Summary unavailable — view the original SEC filing for the full text.

Filing: 8-K (Material Event)
Form 8-K Material Company Update 2026-08-06

ZTS filed 8-K — material company event

Zoetis Inc. filed an 8-K with the SEC reporting a material event. Summary unavailable — view the original SEC filing for the full text.

Filing: 8-K (Material Event)
Form 8-K Material Company Update 2026-08-06

ZTS filed 8-K — material company event

Zoetis Inc. filed an 8-K with the SEC reporting a material event. Summary unavailable — view the original SEC filing for the full text.

Filing: 8-K (Material Event)
Periodic Reports 1 · Forms 10-K and 10-Q

The periodic reports are where the audited and reviewed financial statements live. This period contains 1 quarterly report (10-Q) for Zoetis Inc.

The two are not equivalent in weight. A 10-K is audited by an external firm and includes the full risk factor disclosure, business description and management discussion; a 10-Q is unaudited, reviewed rather than examined, and much shorter. When a figure in a quarterly report is later revised, the annual report is usually where the correction appears.

An amended report — 10-K/A or 10-Q/A — restates or corrects something in the original filing, and is worth reading against the version it replaces.

Form 10-Q Quarterly Report 2026-08-06

ZTS filed Quarterly Report (10-Q)

Zoetis Inc. filed its quarterly report with the SEC. This report includes unaudited financial statements and management discussion for the quarter.

Filing: 10-Q (Quarterly Report)

How we classify Zoetis Inc.'s filings

Straight from EDGAR

Each displayed record links to an original source document. StrongBuyAnalytics provides navigation and brief excerpts or summaries, not the filing itself. Parsing may omit context or contain errors, so read the original document in full.

Transaction codes, not guesswork

The nature shown on each insider filing comes from the transaction code the filer entered on the form itself — P for an open-market purchase, A for a compensation award, F for shares withheld to pay tax, M for an option exercise. Where one filing contains several codes, the transaction table lists them line by line.

Why the distinction matters

Insider activity is routinely summarised as buying or selling, which flattens together decisions that mean very different things. Shares withheld for tax on a vesting grant are an automatic administrative step; shares bought on the open market are someone committing their own money at the current price.

What this page does not tell you

A filing records what happened, not why. Form 4 does not always disclose whether a sale was executed under a pre-arranged Rule 10b5-1 plan, and no single filing is a basis for a decision on ZTS. Read these alongside the fundamentals rather than in isolation.

Frequently Asked Questions — ZTS SEC Filings

More Tools for ZTS

Want deeper ZTS analysis?

View valuation, growth metrics, the rule-based stock-page score, demand zones, peer comparison, and more — all on the ZTS stock analysis page.

ZTS Full Analysis
Publisher, sources & limitations — September 15, 2026. StrongBuyAnalytics provides navigation and brief excerpts or summaries for educational use. Original filings remain at SEC EDGAR or other displayed source links; StrongBuyAnalytics does not author them. Filing dates are source dates, not publication dates for this page. Coverage can be delayed, incomplete, amended, or unavailable because of SEC/source availability, parsing, caching, or outages. Verify every material statement in the original filing.
Data Sources · Methodology · AI Disclosure · Corrections Policy · Disclaimer